Russian Association of Endocrinologists clinical practice guidelinesfor diagnosis, treatment and preventive measures in congenital adrenal hyperplasia due to 21-hydroxylase deficiency patients in adulthood

Cover Page

Cite item

Full Text

Abstract

Russian clinical practice guidelines presents the main approaches to the diagnosis, treatment and follow-up of patients with classical and nonclassical forms 21-hydroxylase deficiency. The techniques of diagnostic tests and parameters of hormonal indicators to assess the adequacy of replacement therapy glucocorticoids and mineralocorticoids are considered.

About the authors

G. A Melnichenko

Endocrinology research center of the Ministry of Health of the Russian Federation

акад. РАН, д-р мед. наук, проф., дир. Института клинической эндокринологии ФГБУ «Эндокринологический научный центр» Минздрава России 117036, Russian Federation, Moscow, ul. Dmitria Ul'ianova, d. 11

E. A Troshina

Endocrinology research center of the Ministry of Health of the Russian Federation

д-р мед. наук, проф., зав. отд-ния терапии с группой ожирения ФГБУ «Эндокринологический научный центр» Минздрава России 117036, Russian Federation, Moscow, ul. Dmitria Ul'ianova, d. 11

N. V Molashenko

Endocrinology research center of the Ministry of Health of the Russian Federation

Email: molashenko@mail.ru
канд. мед. наук, вед. науч. сотр. отд-ния терапии с группой ожирения ФГБУ «Эндокринологический научный центр» Минздрава России molashenko@mail.ru

A. I Sazonova

V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

канд. мед. наук, врач, терапевтическое отд-ние ФГБУ НЦАГиП им. акад. В.И.Кулакова 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

Zh. A Uzhegova

Endocrinology research center of the Ministry of Health of the Russian Federation

врач отд-ния эндокринной гинекологии ФГБУ «Эндокринологический научный центр» Минздрава России 117036, Russian Federation, Moscow, ul. Dmitria Ul'ianova, d. 11

References

  1. Федеральные клинические рекомендации - протоколы по ведению пациентов с врожденной дисфункцией коры надпочечников в детском возрасте. Пробл. эндокринологии. 2014; 2: 42-50.
  2. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95 (9): 4133-60.
  3. Speiser P.W, Dupont B, Rubinstein P et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37: 650-67.
  4. Сазонова А.И. Соматический статус и метаболические нарушения у взрослых пациентов с различными формами врожденной дисфункции коры надпочечников. Дис. … канд. мед. наук. М., 2013.
  5. Azziz R, Hincapie L.A, Knochenhauer E.S et al. Screening for 21-hydroxylase - deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999; 72: 915-25.
  6. Bidet M, Bellanné-Chantelot C, Galand-Portier M.B et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009; 94: 1570-8.
  7. Török D, Halasz Z, Garami M et al. Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes 2003; 111: 27-32.
  8. Bidet M, Bellanné-Chantelot C, Galand-Portier M.B et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95: 1182-90.
  9. Moran C, Azziz R, Weintrob N et al. Reproductive outcome of women with 21-hydroxylase - deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91: 3451-6.
  10. New M.I. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91: 4205-14.
  11. Riepe F.G, Krone N, Viemann M et al. Management of congenital adrenal hyperplasia: results of the ESPE questionnaire. Horm Res 2002; 58: 196-205.
  12. Brunton L.L. Goodman & Gilman’s the pharmacological basis of therapeutics. McGraw Hill, 2006.
  13. Charmandari E, Matthews D.R, Johnston A et al. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 2001; 86: 4679-85.
  14. Rosenfield R.L. Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2002; 87: 2993.
  15. Spritzer P, Billaud L, Thalabard J.C et al. Cyproterone acetate versus hydrocortisone treatment in late - onset adrenal hyperplasia. J Clin Endocrinol Metab 1990; 70: 642-6.
  16. Merke D.P, Bornstein S.R. Congenital adrenal hyperplasia. Lancet 2005; 365: 2125-36.
  17. Stikkelbroeck N.M, Oyen W.J, van der Wilt G.J et al. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003; 88: 1036-42.
  18. Falhammar H, Filipsson H, Holmdahl G et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92: 110-6.
  19. Zimmermann A, Grigorescu-Sido P, Al-Khzouz C et al. Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 2010; 74 (1): 41-9.
  20. Bachelot A, Chakhtoura Z, Samara-Boustani D et al. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol 2010.
  21. Barzon L, Sonino N, Fallo F et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149: 273-85.
  22. Varan A, Unal S, Ruacan S, Vidinlisan S. Adrenocortical carcinoma associated with adrenogenital syndrome in a child. Med Pediatr Oncol 2000; 35: 88-90.
  23. Hague W.M, Adams J, Rodda C et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990; 33: 501-10.
  24. Bryan S.M, Honour J.W, Hindmarsh P.C. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. J Clin Endocrinol Metab 2009.
  25. Merza Z, Rostami-Hodjegan A, Memmott A, Doane A. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2006; 65: 45-50.
  26. Verma S, Sinaii N, Kim M.S et al. A pharmacokinetic and pharmacodynamic study of delayed - and extended release hydrocortisone (ChronocortTM) versus conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2010; 72: 441-7.
  27. Cabrera M.S, Vogiatzi M.G, New M.I. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 3070-8.
  28. Claahsen - van der Grinten H.L, Otten B.J, Hermus A.R et al. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage. Fertil Steril 2008; 89: 597-601.
  29. Charmandari E, Brook C.G, Hindmarsh P.C. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Arch Dis Child 2002; 86: 266-9.
  30. Hagenfeldt K, Janson P.O, Holmdahl G et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23: 1607-13.
  31. Файзулин А.К., Батыгин М.П., Глыбина Т.М., Шкитырь З.В. Современные методы хирургической коррекции пороков наружных гениталий у девочек с врожденной дисфункцией коры надпочечников. Андрология и генитальная хирургия. 2011; 3: 69-73.
  32. Casteras A, De Silva P, Rumsby G, Conway G.S. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009; 70: 833-7.
  33. Lo J.C, Schwitzgebel V.M, Tyrrell J.B et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 930-6.
  34. Hughes I.A, Houk C, Ahmed S.F, Lee P.A. Consensus statement on management of intersex disorders. Arch Dis Child 2006; 91: 554-63.
  35. Dessens A.B, Slijper F.M, Drop S.L. Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 2005; 34: 389-97.
  36. Meyer-Bahlburg H.F, Dolezal C, Baker S.W, New M.I. Sexual orientation in women with classical or non - classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav 2008; 37: 85-99.
  37. Зубкова Н.А., Дворянчиков Н.В., Окулов А.Б., Касаткина Э.П. Психосексуальный статус больных с врожденной дисфункцией коры надпочечников. Успехи теоретической и клинической медицины: материалы научных исследований РМАПО. М., 2003; с. 228-9.
  38. Meyer-Bahlburg H.F. Health - related quality of life in intersexuality. Acta Paediatr Suppl 1999; 88: 114-5.
  39. Martin K.A, Chang R.J, Ehrmann D.A et al. Evaluation and Treatment Of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93 (Issue 4): 1105-20.
  40. Андреева Е.Н., Ужегова Ж.А. Врожденная дисфункция коры надпочечников (адреногенитальный синдром): скрининг, диагностика, лечение. Методические рекомендации. М., 2010.
  41. Дедов И.И., Краснопольский В.И., Сухих Г.Т. Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение». Сахарный диабет. 2012; 4: 4-10.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).